Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal immunosuppression in kidney transplant recipients at high risk of new-onset diabetes
2008-005617-22Phase 4Suspended
- Sponsor
- Unidad de Investigación en Salud
- Start
- Feb 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus, cyclosporine and prednisone in diabetes mellitus (DM) and prediabetes (3 arms), sponsored by Unidad de Investigación en Salud. Started Feb 2009; status: suspended.
02
Drugs
tacrolimuscyclosporineprednisone
03
Conditions
diabetes mellitus (DM)prediabetes
Beyond the preview
Go deeper on 2008-005617-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005617-22.